SCHEMBL2767656

SCHEMBL2767656

CCN(CC)C(=O)N1CCN(c2ccc(OCc3ccccc3)c(F)c2)CC1

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 3/20 0.46
ALDH1A1 P00352 3/20 0.46
MAPT P10636 3/20 0.46
GAA P10253 2/20 0.46
TDP1 Q9NUW8 2/20 0.46
HTR6 P50406 2/20 0.45
S1PR5 Q9H228 1/20 0.45
GRM5 P41594 3/20 0.45
PTGDR Q13258 1/20 0.43
LRRK2 Q5S007 2/20 0.43
RORC P51449 2/20 0.43
APP P05067 2/20 0.43
HTR1A P08908 1/20 0.42
ADRA2A P08913 1/20 0.42
ADRA2B P18089 1/20 0.42
ADRA2C P18825 1/20 0.42
DRD1 P21728 1/20 0.42
HRH2 P25021 1/20 0.42
HTR1B P28222 1/20 0.42
HTR2A P28223 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5259717 0.86 MAPT (0.60) KDM4EALDH1A1MAPTGAATDP1
SCHEMBL2769519 0.82 MAPT (0.51) KDM4EALDH1A1MAPTGAATDP1
SCHEMBL5261930 0.81 TLR9 (0.51) KDM4EALDH1A1MAPTGAATDP1
SCHEMBL31181068 0.81 TLR9 (0.51) KDM4EALDH1A1MAPTGAATDP1
SCHEMBL27618503 0.81 HTR6 (0.47) KDM4EALDH1A1MAPTGAATDP1
SCHEMBL2478773 0.80 HTR6 (0.67) MAPTHTR6LRRK2HTR1AADRA2A
SCHEMBL5238577 0.78 GRM5 (0.50) KDM4EALDH1A1MAPTGAATDP1
SCHEMBL2768112 0.77 HTR1A (0.45) KDM4EALDH1A1MAPTGAATDP1
SCHEMBL27637687 0.77 HTR6 (0.45) KDM4EALDH1A1MAPTGAATDP1
SCHEMBL27618506 0.77 HTR6 (0.47) KDM4EALDH1A1MAPTGAATDP1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1627871-B1 CYCLIC AMINOPHENYL SULFAMATE DERIVATIVE ASKA PHARM CO LTD (JP) 2010-04-14 EP disclosed
CN-100467449-C Cyclic aminophenyl sulfamate derivative ASKA PHARM CO LTD (JP) 2009-03-11 CN disclosed
US-7449466-B2 Cyclic aminophenyl sulfamate derivative ASKA PHARMACEUTICAL CO., LTD. (JP) 2008-11-11 US disclosed
US-20060189625-A1 Cyclic aminophenyl sulfamate derivative ASKA PHARMACEUTICAL CO., LTD. (JP) 2006-08-24 US disclosed
CN-1823039-A Cyclic aminophenyl sulfamate derivative ASKA PHARM CO LTD (JP) 2006-08-23 CN disclosed
EP-1627871-A1 CYCLIC AMINOPHENYL SULFAMATE DERIVATIVE Teikoku Hormone Mfg. Co., Ltd. (JP) 2006-02-22 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20060189625-A1 Cyclic aminophenyl sulfamate derivative SHBG, STS, ARSA KDM4E 692/4885ALDH1A1 2953/4885MAPT 4852/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.